IDH2 and astrocytoma (excluding glioblastoma): Consistent with previous series, the impact of postoperative tumor volume on survival was greater in the IDH-mutant astrocytoma subgroup than in the IDH-mutant 1p19q codeleted oligodendroglioma subgroup.